Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See All DiscoveriesBy concentrating philanthropic, scientific, and business development resources during the high-risk stages of drug development, Harrington ‘de-risks’ therapeutic candidates and positions them for further investment and commercialization.
Learn More
Renowned US Neuroscientist and Harvard Professor brings extensive expertise in academia and industry to advance rare disease research
Continue Reading
Award highlights collaboration between for profit and non-profit achieving great impact
Continue Reading
Scholar Award Accelerates Novel Therapies for Rare Diseases
Continue Reading
Next Generation Medicines
Continue Reading